This study was designed to determine whether opioid mixed agonist-antagonist analgesics other than buprenorphine also selectively reduce cocaine self tzdministration by rhesus monkeys. The effects of daily treatment with nalbuphine (0.1 to 3 mglkglday) or (0.254 to 7.62 p.mollkglday), butorphanol (0.01 to 0.3 mglkglday) or (0.0209 to 0.628 p.mollkglday), and saline on cocaine and food self-administration were each studied {Dr 40 sessions over 10 consecutive days. Cocaine (0.05 or 0.10 mglkglinj) and food (l-gm banana pellets) self-administration were maintained on a fixed ratio 4 (variable ratio 16:5) schedule of reinforcement. Both nIllbuphine and butorphanol reduced cocaine self-administration (p < 0.0001) but this effect was not selective since food self-administration also decreased in a dose-dependent manner (p < 0.0001). Nalbuphine administration (1 to 3 mglkglday) decreased cocaine injections to 40% to 60% below baseline (p < 0.01) and food pellets 30% to 68% below baseline (p < 0.01).
dose-dependent manner (p < 0.0001). Nalbuphine administration (1 to 3 mglkglday) decreased cocaine injections to 40% to 60% below baseline (p < 0.01) and food pellets 30% to 68% below baseline (p < 0.01).
Lower doses of nalbuphine (0.10 and 0.30 mglkg) did not change cocaine-or food-maintained responding significantly. All doses of butorphanol (0.01 to 0.3 mglkglday) reduced cocaine injections to 16% to 58% below baseline (p < 0.01). Food self-administration decreased to 21% to 70% below baseline (p < 0.01) at butorphanol doses of 0.03 to 0.3 mglkglday). These data suggest that these opioid mixed agonist-antagonist analgesics may not be useful as pharmacotherapies for the treatment of cocaine abuse. lNeuropsychopharmacology 8: 45-55, 1993J nist analgesic, buprenorphine, may be useful for the treatment of cocaine abuse by poly drug abusers Mendelson et al. 1991; Gastfriend et al. 1992) . Previous studies have shown that buprenor phine signifIcantly decreased heroin self-administration by heroin-dependent men (Mello and Mendelson 1980; Mello et al. 1982 ) and opiate self-administration by rhe sus monkeys (Mello et al. 1983) . The present report is one of a series of studies designed to evaluate the effects of opioid mixed agonist-antagonist analgesics on co caine self-administration in a primate model of drug abuse (Mello et al. 1989 (Mello et al. , 1990 .
We recently reported that buprenorphine selec tively reduced cocaine self-administration by rhesus monkeys by 72% to 93% (Mello et al. 1989 (Mello et al. , 1990 ) and cocaine self-administration remained signmcantly be low saline treatment baseline levels for up to 120 days . Ongoing Phase I clinical trials indi-cate that buprenorphine also decreases cocaine abuse by men who are dually dependent on cocaine and heroin according to DSM-III-R criteria (Gastfriend et al. 1992; Mello and Mendelson 1992) . Buprenorphine was more effective than methadone in reducing cocaine self-administration by heroin abusers (Kosten et al. 1989a (Kosten et al. , 1989b . The mechanics by which buprenorphine reduces cocaine self-administration are unclear, but may involve an interaction between dopaminergic and en dogenous opioid peptide systems (Mello and Mendel son 1992; Mello et al. 1990 ) since the reinforcing and discriminative stimulus effects of cocaine are modulated by dopaminergic neural systems (for review see Dackis and Gold 1985; Fischman 1987; Johanson and Fischman 1989; Kuhar et al. 1988) .
One goal of the present study was to determine if other opioid mixed agonist-antagonist analgesics also selectively reduce cocaine self-administration by rhe sus monkeys. Nalbuphine and butorphanol were se lected for study since both are currently approved by the Food and Drug Administration for use as analgesics and the pharmacology of these compounds has been studied extensively (Errick and Heel 1983; Pachter and Evans 1985; Schmidt et al. 1985) . A second objective was to examine the extent to which differences in the putative opioid receptor affm ities of these opioid mixed agonist-antagonists might influence their effects on co caine self-administration.
Although nalbuphine, butorphanol, and buprenor phine were originally developed as analgesics, these opioid mixed agonist-antagonist drugs diff er in chemi cal structure and opioid receptor affinities (for review see Jaffe and Martin 1990; Pachter and Evans 1985; Pircio et al. 1976; Schuster and Harris 1985) . Nalbuphine and butorphanol are from the morphinan series (Schmidt et al. 1985; Woolverton and Schuster 1983) whereas buprenorphine is an oripavine derivative of thebaine (Lewis 1974; Lewis et al. 1983) . Both nalbuphine and butorphanol have partial � and K agonist activity (Dyk stra 1990; Woods and Gmerek 1985) as well as � an tagonist opiate receptor activity (Jaffe and Martin 1990; Schmidt et al. 1985) but their relative receptor selectivity varies with the type of assay as well as the species stud ied (De Souza et al. 1988; Dykstra 1990 ). The analgesic effects of these drugs may involve more than one opi oid receptor. Both � and K agonist activity appear to contribute to their analgesic actions (De Souza et al. 1988; Goodman and Snyder 1982; Zimmerman et al. 1987 ), but butorphanol antagonizes K and � agonists in some behavioral measures (Dykstra, 1990; Woods and Gmerek, 1985) . In contrast, buprenorphine is a par tial agonist at the � opioid receptor and has K antagonist as well as � antagonist activity in both physiologic and behavioral systems (Jaffe and Martin 1990; Mello et al. 1982; Leander 1987; Negus and Dykstra 1988; Negus et al. 1991; Richards and Sadee 1985) . NEUROPSYCHOPHARMACOLOGY 1993-VO L. 8, NO .1 The effects of nalbuphine and butorphanol on co caine self-administration were examined with be havioral procedures identical to those previously used to evaluate buprenorphine's effects on cocaine self administration (Mello et al. 1989 (Mello et al. , 1990 . Daily treatment with nalbuphine (0.1 to 3 mg/kg/day or 0.254 to 7.62 �mol/kg) or butorphanol (0.01 to 0.3 mg/kg/day or 0.0209 to 0.628 �mollkg) was compared with saline treatment. Saline and each dose of nalbuphine and butorphanol were studied for 10 days. Food-maintained responding was also studied to determine if any changes in cocaine self-administration during nal buphine or butorphanol treatment were selective for drug-maintained responding, or reflected a generalized suppression of operant behavior. The importance of ex amining treatment drug effects on an alternative rein forcer, such as food, has been discussed elsewhere (Mello 1991 (Mello , 1992 .
SUBJECTS AND METHODS

Animals
Six rhesus monkeys (Macaca mulatta) (three females and three males) with a history of intravenous cocaine self administration were studied. At the beginning of this study, the nalbuphine group averaged 563 days of co caine self-administration (range 126 to 995 days) and the butorphanol group averaged 611 days of cocaine self-administration (range 175 to 1,040 days). Monkeys weighed 7.3 to 12.2 kg and were maintained at ad libi tum weight throughout the study. Monkeys were given two to four Purina Chow biscuits, multiple vitamins, fresh fruit (apple, orange, banana) and vegetables (let tuce, carrots) to supplement a banana pellet diet; wa ter was continuously available. A 12-hour light/dark cy cle was in effect (lights on from 7 A.M. to 7 P.M.) except that the experimental chamber was dark during food and drug self-administration sessions. (Line 1987; Line et al. 1989 ).
Operant Behavioral Procedures and Apparatus
Monkeys worked at an operant task for l-gm banana pellets and for intravenous cocaine injections in a well ventilated chamber equipped with an operant panel, a pellet feeder, and a water dispenser. Cocaine injec tions were delivered by a syringe pump in a single pulse that dispensed 0.1 ml of fluid over 0.9 seconds. The operation of the syringe pump (Model 981210, Harvard Apparatus, Inc., South Natick, MA) was audible to the monkey. Schedules of reinforcement were program med by custom designed software and run on Apple fie microcomputers.
Cocaine self-administration was studied at the dose that maintained the highest response rates during train ing in each monkey (0.05 or 0.10 mg/kg/inj). Cocaine doses lower and higher than the most reinforcing dose were not examined because nalbuphine and butor phanol each suppressed food-maintained responding across the dose range studied. These cocaine doses per injection were identical to those previously used in par allel st udies of buprenorphine treatment (Mello et al. 1989 (Mello et al. ,1990 . Food (l-gm banana pellet) and cocaine self administration were maintained on a second-order schedule of reinforcement [fIxed ratio 4 (FR 4), variable ratio (VR 16):S]. An average of 16 responses on a VR 16 produced a brief red or green stimulus light (S + ) and a drug injection or a food pellet was delivered only after a FR 4 of the VR 16 response requirements had bee n completed. Thus, each food pellet or drug injec tion required an average of 64 responses. Additional details of the apparatus have been published previously (Mello and Mendelson 1978) .
The conditions of food and cocaine availability were each associated with a different colored stimulus light (5+) projected on a translucent Plexiglas response key (5 em diameter) in the center of the operant panel. The stimulus lights (S+) were extinguished during time out periods when responses had no programmed con sequence. When a food pellet or drug injection was de-livered, the appropriate colored stimulus light (S + red or green) was illuminated for 1 second on the middle of 3 circles (2 cm diameter) located in a vertical column below the response key. These I-second colored stimu lus light flashes (S + ) also signaled the completion of each successive component of the second-order schedule response requirement.
Operant food and drug acquisition sessions were conducted 7 days each week. Each experimental day consisted of four food-and four-drug-availability ses sions. Each food or drug session lasted for 1 hour or until 100 food pellets or 20 drug injections were deliv ered. Cocaine injections were limited to 80 per day to minimize the possibility of adverse drug effects. Food sessions began at 11:00 A.M., 3:00 P.M., 7:00 P.M., and 7:00 A.M. and drug sessions began 1 hour later at 12 noon, 4:00 P.M., 8:00 P.M., and 8:00 A.M.
Butorphanol and Nalbuphine Administration
The range of doses of butorphanol and nalbuphine studied were selected on the basis of their behavioral effects in previous studies Woods and Gmerek 1985; Young et al. 1984) . Butorphanol is 3 to 30 times more potent than nalbuphine in studies de signed to examine the reinforcing and discriminative stimulus properties of opioid mixed agonist-antagonist drugs Woods and Gmerek 1985; Young et al. 1984 ). The results of preliminary studies of the effects of nalbuphine on cocaine suggested that 1 mg/kg of nalbuphine reduced rates of responding maintained by cocaine (0.01 mg/kg/inj) from 1.8 to 0.4 responses per second (JH Woods, personal communi cation, 1990) . Accordingly, we studied nalbuphine's effects on cocaine and food self-administration over a dose range of 0.1 to 3 mg/kg/day [0.254 to 7.62 Ilmollkg/day]. Butorphanol was studied over a dose range of 0.03 to 1 mg/kg/day [0.0209 to 0.628 Ilmol /kg/day]. The effects of nalbuphine and butorphanol were assessed in the same four subjects; nalbuphine was studied frrst and butorphanol was studied second. Two other monkeys received only nalbuphine (CH 84) or only butorphanol (199C).
After 10 days of saline treatment, the effects of daily butorphanol treatment or daily nalbuphine treatment were studied for 10 days (40 sessions) at each dose. Af ter completion of nalbuphine or butorphanol treatment, saline treatment was resumed and recovery of cocaine and food-maintained responding was observed over 10 to 30 days. All drug doses were given in an ascending order except for butorphanol in Monkey 1937.5 where the lowest dose tested (0.003 mg/kg/day) was studied last. Two monkeys (CH 84 and 1937.5) were not stud� ied at the lowest dose of nalbuphine.
Butorphanol, nalbuphine, or an equal volume of saline control solution was administered once each day in a slow injection between 9:30 A.M. and 10:30 A.M.
Each solution was gradually infused at a rate of 1 ml of solution every 10 minutes and flushed through with sterile saline in a volume that exceeded the estimated catheter dead space. The duration of nalbuphine's an algesic action is 3 to 6 hours (Forbes et al. 1984; Schmidt et al. 1985) . The plasma half-life of an analgesic dose of nalbuphine (10 to 20 mg) after intravenous adminis tration in healthy volunteers has been estimated at be tween 1.9 and 3.7 hours (Aitkenhead et al. 1988 ); Jail Ion et al. 1989; Lo et al. 1987) . The pharmacokinetic proftle of butorphanol is similar to that of nalbuphine.
The plasma half-life of butorphanol is about 3 hours and it is effective as an analgesic for up to 4 hours (Jaffe and Martin 1990; Pachter and Evans 1985) . In the present study, the time course of changes in the effects of butor phanol and nalbuphine on food and cocaine self-ad ministration were measured across four successive food and drug sessions that spanned 0.5 to 22.5 hours after treatment drug administration.
Butorphanol and Nalbuphine Preparation. Butor phanol HO was purchased as a 10 mg/ml commercially available solution (Torbugesic, Aveco Co., Inc., Fort Dodge, Iowa). Sterile stock solutions of 1 or 5 mg/ml were diluted from the commercially prepared solution by adding Sterile Saline for Injection, U.S.P. Nal buphine HO was donated by the DuPont Merck Phar maceutical Corporation, Wilmington, Delaware. Nal buphine was dissolved in saline to a concentration of 5, 10, or 20 mg/ml. These stock solutions were ftlter sterilized using a 0.22 micron Millipore ftlter and stored in pyrogen-free vials. Stock solutions were diluted with sterile saline to deliver the appropriate milligram per kilogram dose in a volume of 5 ml. Solutions were checked daily to ensure that no precipitate had formed.
Fresh stock solutions were prepared at least once a month.
Cocaine Preparation. Cocaine hydrochloride was ob tained in crystalline form from National Institute on Drug Abuse. The purity was certifIed by Research Tri angle to be greater than 98%. Stock solutions of 50 mg/ml were prepared by dissolving cocaine in Sterile Saline for Injection, U.S.P. The solution was ftlter sterilized using a 0.22 micron millipore ftlter and stored in sterile pyrogen-free vials. Doses were calculated on the basis of monkeys' weights so that a £mal dilution of the stock solution (with Sterile Saline for Injection, U.S.P.) resulted in a unit dose of 0.05 orO.10 mg/kg/inj in a volume of 0.1 ml/inj.
Data Analysis
Butorphanol and nalbuphine effects on cocaine-and food-maintained responding were evaluated with one way analysis of variance (ANOV A) for repeated mea- self-administration decreased to 30% and 68% below baseline (p < 0.05 -0.01). Figure 2 shows the effects of nalbuphine and sa line on cocaine and food self-administration by in dividual monkeys. Nalbuphine treatment signifIcantly decreased cocaine self-administration in all nve mon keys (p < 0.001). Food self-administration decreased signiflcantly in three of nve monkeys (CH84, 1937.5, 679C) (p < 0.001) (Fig. 2, rows 1 to 3) . Food self administration did not change signifIcantly from base line in one monkey (606.5) and increased signifIcantly (p< 0.001) in one monkey (371A) (Fig. 2, rows 4 and 5) .
Monkeys diff ered in the degree of suppression of cocaine-and food-maintained responding by nal buphine as well as in the time required to return to base line levels after nalbuphine treatment ended. Monkey �l : � �C _I: Nalbuphine (mglkg/day) FJSUR! 2. Effects of daily nalbuphine treatment or saline treat ment on cocaine and food self-administration by individual monkeys. Each data point is the average (± SE) of 10 days of cocaine or food self-administration. The average number of cocaine injections self-administered per day is shown as circles. The average number of banana pellets self administered per day by each monkey is shown as squares.
The statistical significance of each change from the saline treat ment baseline is indicated by an asterisk (*p<O.OS; **p< 0.01).
371A showed a signifIcant increase in food-maintained responding throughout nalbuphine treatment (p < 0.01) and this was sustained during the 10-day postnal buphine saline recovery period (Fig. 2, row 5) . Cocaine maintained responding returned to baseline levels within 10 days after nalbuphine treatment ended in four of nve monkeys (1937.5, 606.5, 679C, 371A) (Fig. 2 , rows 2 to 5) but remained signifIcantly below baseline for 30 days in Monkey CH84 (Fig. 2, row 1) . Food-maintained responding exceeded baseline levels during the nrst 10 days after nalbuphine treat ment ended in Monkeys 606.5 and 371A (Fig. 2 , rows 4 and 5). Food self-administration recovered within 20 days in Monkey CH84 and within 30 days in Monkey 679C (Fig. 2, rows 1 and 3) . One monkey (1937.5) stabi lized at a relatively high level of food intake (92 ± 10.4 pellets per day) but did not recover to his prenalbuphine baseline level (Fig. 2, row 2 ).
Time Course of Nalbuphine's Effects on Cocaine and Food Self-Administration Figure 3 shows the effects of saline and each dose of nalbuphine on cocaine-and food-maintained respond ing over consecutive sessions each day. During treat ment with saline and 0.1 mg/kg/day nalbuphine, co caine injections were evenly distributed across the four sessions. Higher doses of nalbuphine (1 to 3 mg/kg/day) decreased cocaine injections by 72% to 90% during the noon session that began 1.5 hours after nalbuphine. Co caine injections remained 24% to 63% below baseline (p < 0.01) during the 4 P.M. and 8 P.M. sessions that be gan 5.5 and 9.5 hours after 1 and 3 mg/kg/day of nal buphine. Cocaine-maintained responding tended to re turn toward baseline levels by the 8 A.M. session, 21.5 hours after nalbuphine treatment.
Food-maintained responding was also evenly dis tributed across the four daily sessions during saline treatment (Fig. 3) . All doses of nalbuphine decreased food self-administration during the 11:00 A. M. session, 30 minutes after nalbuphine treatment. There was a compensatory increase in food self-administration to 70% to 91% (p < 0.01) over baseline levels during the 3:00p.M. and 7:00p.M. sessions, 4.5 and 8.5 hours after nalbuphine (0.1 and 0.3 mg/kg/day). After treatment with the highest dose of nalbuphine (3 mg/kg/day), food self-administration remained suppressed across all four sessions, 30 minutes to 20.5 hours postnalbuphine (Fig. 3 ).
Butorphanol's Effects on Cocaine and Food
Self-Administration
Baseline levels of cocaine self-administration averaged 56.8 ± 2.5 injections per day during 10 days of saline control treatment. The average dose of cocaine self- Three monkeys (199C, 1937.5, 606 .5) returned to saline control levels of food self-administration within 10 days after discontinuation of 0.3 mg/kg! day of butor phanol ( Fig. 5, rows 1,2, and 4) . Food-maintained re sponding recovered more slowly than cocaine- Butorphanol (mg/kglday)
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• Figure 5 . Effect s of daily butorphanol treatment or saline treatment on cocaine and food self-administration by in dividual monkeys. Each data point is the average (± SE) of 10 days of cocaine or food self-administration. The average number of cocaine injections self-administered per day is shown as circles. The average number of banana pellets self-administered per day by each monkey is shown as squares.
The statistical signifIcance of each change from the saline treat ment baseline is indicated by an asterisk (*p < 0.05; **p < 0.01).
maintained responding after butorphanol treatment in two monkeys (679C, 371A) (Fig. 5 , rows 3 and 5). Mon key 371A dislodged her catheter 21 days after butor phano l treatment ended.
Time Course of Butorphanol's Effects on Cocaine and Food Self-Administration Figure 6 shows the effects of each dose of butorphanol on cocaine self-administration over consecutive drug availability sessions 1.5 to 21.5 hours after butorphanol treatment. Figure 6 shows butorphanol's effects on food self-administration, 30 minutes to 20.5 hours after butor phanol treatment. Cocaine injections w ere evenly distributed across the four daily sessions during saline treatment (Fig. 6 ). Cocaine Sessions (time of day) Butorphanol produced dose-related decreases in co caine self-administration during the 12:00 noon session.
These decreases were sustained during the 4:00 P.M. and 8:00 P.M. sessions after 0.10 and 0.30 mg/kg/day of butorphanol. The degree of suppression of cocaine maintained-responding during the 8:00 A.M. session was equivalent after all doses of butorphanol (Fig. 6 ).
After 0.1 and 0.3 mg/kg/day of butorphanol, cocaine self-administration during the 8:00 A.M. session was signifIcantly higher than during the noon session (p < 0.01). Food self-administration was reduced by all doses of butorphanol to 53% to 99% below baseline during the 11:00 A.M. sessions (Fig. 6 ). By 3:00 P.M., food self administration increased above baseline levels after low doses of butorphanol (0.01 and 0.03 mg/kg/day) but re mained 65% to 77% below baseline after higher doses of butorphanol (0.1 and 0.3 mg/kg/day). By 7:00 P.M. food self-administration returned to baseline levels except after the highest dose of butorphanol (0.3 mg/ kg/day). By 7:00 A.M., food-maintained responding af ter all doses of butorphanol was similar to saline con trol treatment levels. Food-maintained responding af ter 0.1 and 0.3 mg/kg/day of butorphanol was signifIcantly higher during the 7:00 A.M. sessions (p < 0.01) than during the 11:00 A.M. sessions (Fig. 6 ).
DISCUSSION Cocaine Self-Administration During Nalbuphine and Butorphanol Treatment
This is the fIrst report of the effects of these opioid mixed agonist-antagonist analgesics on concurr ent cocaine and food self-administration by rhesus monkeys. Nal buphine and butorphanol treatment were each as sociated with signifIcant (P < 0.0001) dose-dependent decreases in cocaine self-administration. The highest dose of nalbuphine (3 mg/kg/inj) and butorphanol (0.3 mg/kg/inj) reduced the number of cocaine injections from equivalent baseline levels (58.7 ± 2.1 and 56.8 ± 2.5 inj/day) to similar nadirs (23 ± 2.4 and 21.18 ± 2.14 inj/day) (Figs. 1 and 4) . The average daily dose of co caine self-administered decreased from baseline levels of 3.91 ± 0.49 and 4.06 ± 0.91 mg/kg/day to 1.73 ± 1.5 and 1.58 ± 1.2 mg/kg/day. Individual patterns of co caine self-administration during nalbuphine and butor phanol treatment (Figs. 2 and 5) were consistent with the group average data (Figs. 1 and 4) . But two mon keys were more sensitive to butorphanol's effects on cocaine-maintained responding than to nalbuphine (Figs. 2 and 5, rows 3 and 4) .
It is noteworthy that the effects of each dose of nal buphine and butorphanol were relatively constant across each 10-day period of observation ( Figs. 1 and  4) . Consequently, we conclude that tolerance to the effects of nalbuphine and butorphanol on cocaine self administration over 40 days of treatment did not oc cur. Cocaine self-administration rapidly returned to baseline levels after cessation of nalbuphine (Fig. 2) or butorphanol treatment (Fig. 5 ). This pattern of recov ery suggests that nalbuphine or butorphanol treatment, and not uncontrolled variables, accounted for the decreases in cocaine self-administration observed.
The maximum effects of each treatment drug oc- NEUROPSYCHOP HARMACOLOGY 1993-VOL. 8, NO. 1 curred during the nrst, second, and third daily cocaine session, 1.5,5.5, and 9.5 hours after the end of the nal buphine or butorphanol infusion (Figs. 3 and 6 ). Daily cocaine self-administration occurred primarily in the 8:00 A.M. session, 21.5 hours after nalbuphine or butor phanol administration. The relatively short duration of action of these compounds would limit their usefulness as pharmacotherapies for cocaine abuse. Nalbuphine's suppressive effects on cocaine self administration are consistent with a previous observa tion that nalbuphine (1 mg/kg) reduced cocaine-main tained response rates in rhesus monkeys (JH Woods, personal communication, 1990) . However, nalbuphine effects on food-maintained responding were not exam ined in that study OH Woods, personal communica tion, 1990) .
Butorphanol was approximately 10 times more po tent than nalbuphine in reducing cocaine self-admin istration (compare Figs. 1 and 4) . These data are in ac cordance with previous reports that the reinforcing and discriminative-stimulus properties of butorphanol are 3 to 30 times more potent than nalbuphine Woods and Gmerek 1985; Young 1991; Young et al. 1984 ).
Food Self-Administration During Nalbuphine and Butorphanol Treatment
A dose-dependent decrease in food self-administration (p < 0.001) also occurred during treatment with both nalbuphine and butorphanol (Figs. 1 and 4) . Butor phanol reduced food-maintained responding in each individual monkey (Fig. 5 ) whereas some doses of nal buphine were associated with increased food self administration (Fig. 2, rows 3 and 4) . In one instance, food self-administration during the prenalbuphine sa line treatment was lower than that measured in any other monkey and remained lower during the postnal buphine saline treatment period (Fig. 2, row 5) . Recov ery of food-maintained responding tended to be more rapid after termination of butorphanol treatment than after cessation of nalbuphine treatment (Figs. 2 and 5 ); yet during nalbuphine and butorphanol treatment, the pattern of recovery of food self-administration across sessions within a day was quite similar for the two drugs (Figs. 3 and 6 ).
These fIndings confIrm and extend previous reports that butorphanol and nalbuphine reduce rates of food maintained responding in the absence of cocaine (Harris 1980; Lukas et al. 1986 ). Butorphanol and nalbuphine suppressed food-maintained responding in baboons at doses similar to those in the present study but ad libi tum food consumption was either not affected or was slightly elevated during 15 daily sessions of butorphanol or nalbuphine self-administration (Lukas et al. 1986 ). It was possible, although difficult, to antagonize the rate-suppressant effects of butorphanol with naloxone, suggesting that this effect may not be solely linked with asingle opiate receptor (Harris 1980) . The observed de crease in food self-administration following treatment with these K agonists is not consistent with reports that Kagonists induce feeding (Billington et al. 1990 ; Jack son and Cooper 1986; Levine and Morley 1983; Lynch etal.1985; Morley et al. 1982 Morley et al. , 1983 Poggioli et al. 1986 ).
But it is important to distinguish between feeding, a biologically based consumatory behavior, and schedule controlled behavior where food is a reinforcer (Lukas et aI. 1986 ).
Implications for Treatment of Cocaine Abuse
with Nalbuphine and Butorphanol
Since nalbuphine and butorphanol treatment reduced both cocaine-and food-maintained responding, their effects were not selective for cocaine. Rather, the par aJlel dose-dependent decreases in cocaine and food self administration (Figs. 1 and 4) suggest that these drugs exerted a general suppressant effect on operant be havior. These data contrast sharply with the effects of ano ther opioid mixed agonist-antagonist, buprenor phine, on cocaine and food self-administration. We pre viously reported that buprenorphine selectively re duc ed cocaine self-administration by three monkeys (CH84, 679C, 199C) that were also subjects in the pres ent study (Figs. 2 and 5) (Mello et al. 1990 ). Buprenor phine reduced cocaine self-administration by 72% to 93% and although food self-administration was initially su ppressed, this effect was not dose dependent and tolerance developed to buprenorphine's suppressive effects on food intake (Mello et al. 1989 (Mello et al. , 1990 .
Since cocaine self-administration remained suppressed while food self-administration returned to baseline lev els, we concluded that buprenorphine had a selective effect on cocaine self-administration (Mello et al. 1989 (Mello et al. , 1990 . Acute buprenorphine administration usu ally reduces food self-administration (Dykstra 1983; Leander 1983; Lukas et al. 1986; Mello et al. 1985) but tolerance develops during chronic administration (Lu kas et al. 1988; Mello et al. 1981 Mello et al. , 1985 Mello et al. , 1992 . antagonist actions under some conditions. Nalbuphine and butorphanol each have K agonist activity (Jaffe and Martin 1990; Schmidt et al. 1985) , whereas buprenor phine has K antagonist activity (Jaffe and Martin 1990;
Butorphanol and Nalbuphine 53 Negus and Dykstra 1988; Negus et al. 1991; Richards and Sadee 1985) . The extent to which buprenorphine's K antagonist properties may be a critical factor in its selective effects on cocaine self-administration remains to be determined (see Mello and Mendelson 1992) since butorphanol and nalbuphine also have partial K an tagonist effects in some paradigms (Dykstra 1990 ).
Butorphanol was more potent than nalbuphine as a K antagonist in a shock-titration behavioral paradigm and butorphanol antagonized the effects of both 11 and K agonists on shock-maintained behavior (Dykstra 1990 ).
Although butorphanol's effects on cocaine self-admin istration were not selective in the present study (Figs. 4 and 5), it reduced cocaine-maintained responding in a monotonic dose-dependent manner (Fig. 5) , whereas nalbuphine's effects were less consistent across indi viduals (Fig. 2) .
We conclude that nalbuphine and butorphanol, across the dose range studied, are unlikely to be useful as pharmacotherapies for the treatment of cocaine abuse. The concurrent and sustained reductions in food-maintained behavior and the short duration of ac tion of nalbuphine and butorphanol, compared to buprenorphine Oasinski et al. 1978) , further suggest that these opioid mixed agonist-antagonist analgesics may have limited utility for cocaine abuse treatment.
